These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 9307265)

  • 21. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells.
    Peng X; Maruo T; Cao Y; Punj V; Mehta R; Das Gupta TK; Christov K
    Cancer Res; 2004 Dec; 64(24):8911-8. PubMed ID: 15604252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different mRNA expression profiling of nuclear retinoid, thyroid, estrogen and PPARgamma receptors, their coregulators and selected genes in rat liver and spleen in response to short-term in vivo administration of 13-cis retinoic acid.
    Macejová D; Krizanová O; Brtko J
    Toxicol Lett; 2009 Jan; 184(2):114-20. PubMed ID: 19041696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids.
    Le Q; Dawson MI; Soprano DR; Soprano KJ
    Oncogene; 2000 Mar; 19(11):1457-65. PubMed ID: 10723137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage.
    Chan EC; Lam SY; Tsang KW; Lam B; Ho JC; Fu KH; Lam WK; Kwong YL
    Clin Cancer Res; 2002 Dec; 8(12):3741-6. PubMed ID: 12473584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of tumour suppressor p16 expression in initial stages of oral oncogenesis.
    Vairaktaris E; Yapijakis C; Psyrri A; Spyridonidou S; Yannopoulos A; Lazaris A; Vassiliou S; Ferekidis E; Vylliotis A; Nkenke E; Patsouris E
    Anticancer Res; 2007; 27(2):979-84. PubMed ID: 17465230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of retinoic acid receptors alpha, beta and retinoid X receptor alpha after sciatic nerve injury.
    Zhelyaznik N; Mey J
    Neuroscience; 2006 Sep; 141(4):1761-74. PubMed ID: 16782282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma.
    Banerjee AG; Bhattacharyya I; Lydiatt WM; Vishwanatha JK
    Cancer Res; 2003 Nov; 63(22):7769-76. PubMed ID: 14633702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of effective retinoids for inhibiting growth and inducing apoptosis in bladder cancer cells.
    Zou C; Liebert M; Zou C; Grossman HB; Lotan R
    J Urol; 2001 Mar; 165(3):986-92. PubMed ID: 11176527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gemcitabine as chemotherapy of head and neck cancer in Fanconi anemia patients.
    van Harten AM; Shah R; de Boer DV; Buijze M; Kreft M; Song JY; Zürcher LM; Jacobs H; Brakenhoff RH
    Oncogenesis; 2024 Jul; 13(1):26. PubMed ID: 38992100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation.
    Wils LJ; Buijze M; Stigter-van Walsum M; Brink A; van Kempen BE; Peferoen L; Brouns ER; de Visscher JGAM; van der Meij EH; Bloemena E; Poell JB; Brakenhoff RH
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aging and oral squamous cell carcinoma development: the role of cellular senescence.
    Niklander SE; Aránguiz P; Faunes F; Martínez-Flores R
    Front Oral Health; 2023; 4():1285276. PubMed ID: 37904749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RARβ Expression in Keratinocytes from Potentially Malignant Oral Lesions: The Functional Consequences of Re-Expression by De-Methylating Agents.
    Radhakrishnan R; Crane HL; Daigneault M; Padam KSR; Hunter KD
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemopreventive targeted treatment of head and neck precancer by Wee1 inhibition.
    van Harten AM; de Boer DV; Martens-de Kemp SR; Buijze M; Ganzevles SH; Hunter KD; Leemans CR; van Beusechem VW; Wolthuis RMF; de Menezes RX; Brakenhoff RH
    Sci Rep; 2020 Feb; 10(1):2330. PubMed ID: 32047167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of head and neck carcinoma progression reveals novel and relevant stage-specific changes associated with immortalisation and malignancy.
    Veeramachaneni R; Walker T; Revil T; Weck A; Badescu D; O'Sullivan J; Higgins C; Elliott L; Liloglou T; Risk JM; Shaw R; Hampson L; Hampson I; Dearden S; Woodwards R; Prime S; Hunter K; Parkinson EK; Ragoussis J; Thakker N
    Sci Rep; 2019 Aug; 9(1):11992. PubMed ID: 31427592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HOPX functions as a tumour suppressor in head and neck cancer.
    Yap LF; Lai SL; Patmanathan SN; Gokulan R; Robinson CM; White JB; Chai SJ; Rajadurai P; Prepageran N; Liew YT; Lopes V; Wei W; Hollows RJ; Murray PG; Lambert DW; Hunter KD; Paterson IC
    Sci Rep; 2016 Dec; 6():38758. PubMed ID: 27934959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of HOXB9 and miR-196a in head and neck squamous cell carcinoma.
    Darda L; Hakami F; Morgan R; Murdoch C; Lambert DW; Hunter KD
    PLoS One; 2015; 10(4):e0122285. PubMed ID: 25860510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylation-associated gene silencing of RARB in areca carcinogens induced mouse oral squamous cell carcinoma.
    Lai ZL; Tsou YA; Fan SR; Tsai MH; Chen HL; Chang NW; Cheng JC; Chen CM
    Biomed Res Int; 2014; 2014():378358. PubMed ID: 25197641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of tissue-engineered models of oral dysplasia and early invasive oral squamous cell carcinoma.
    Colley HE; Hearnden V; Jones AV; Weinreb PH; Violette SM; Macneil S; Thornhill MH; Murdoch C
    Br J Cancer; 2011 Nov; 105(10):1582-92. PubMed ID: 21989184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor effect of retinoic acid receptor-beta2 associated with suppression of cyclooxygenase-2.
    Song S; Guan B; Men T; Hoque A; Lotan R; Xu XC
    Cancer Prev Res (Phila); 2009 Mar; 2(3):274-80. PubMed ID: 19258542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-suppressive activity of retinoic acid receptor-beta in cancer.
    Xu XC
    Cancer Lett; 2007 Aug; 253(1):14-24. PubMed ID: 17188427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.